FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Phreesia, Inc. Stock AnalysisComprehensive stock analysis for Phreesia, Inc. (PHR) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisPHR
PHR
Phreesia, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
PHR
Home🔹Stocks🔹Phreesia, Inc.

Phreesia, Inc.

🇺🇸PHR•NYSE

Phreesia, Inc.

🇺🇸PHR•NYSE
Market cap
$637.28M
Sentiment

Your view on PHR

Mkt Cap
$637.28M
Sentiment
Your view
PHR
Phreesia, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
PHR
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Phreesia, Inc.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Chaim Indig
Headquarters
434 Fayetteville Street, Wilmington, NC, US
Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Chaim Indig
Headquarters
434 Fayetteville Street, Wilmington, NC, US
Description

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments.

The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks.

Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients.

In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits.

It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Phreesia, Inc., and the rating behind it. PHR last traded at $10.31, 59.5× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Phreesia, Inc.. Starting points for Phreesia, Inc.: P/E 59.5, EPS $0.17, beta 0.86 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Phreesia, Inc.. Phreesia, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Phreesia, Inc.. Trailing twelve-month EPS for Phreesia, Inc. stands at $0.17. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Phreesia, Inc.. Phreesia, Inc. has reported as a listed company since 2019. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Phreesia, Inc. valued side by side against its closest peers. Phreesia, Inc. is measured against Medical - Healthcare Information Services peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Phreesia, Inc., and how their positions are changing. At a $637.3M market value, institutional positions materially move Phreesia, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Phreesia, Inc. executives and directors. Shares of Phreesia, Inc. have traded between $17.78 and $32.76 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Phreesia, Inc.. Phreesia, Inc. is a $637.3M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Phreesia, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Phreesia, Inc.. Coverage tracks Phreesia, Inc. within Medical - Healthcare Information Services (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • BLFS — BioLife Solutions, Inc.
  • ESTA — Establishment Labs Holdings Inc.
  • GDRX — GoodRx Holdings, Inc.
  • KMTS — KESTRA MEDICAL TECHNOLOGIES, LTD.
  • NEOG — Neogen Corporation
  • NVCR — NovoCure Limited
  • OMCL — Omnicell, Inc.
  • OMDA — Omada Health

More Medical - Healthcare Information Services companies

  • USPS — Ultimate Sports, Inc.
  • VASO — Vaso Corporation
  • VFX.AX — Visionflex Fpo [vfx]
  • VHI.TO — Vitalhub Corp.
  • VHIBF — Vitalhub Corp.
  • VHL.AX — Vitasora Health Limited
  • VRHI — Veri Medtech Holdings Inc.
  • VSEE — VSee Health, Inc.
  • VYND — Vynleads, Inc.
  • WAY — Waystar Holding Corp.
  • WLSS — Welsis Corp.
  • WMGR — Wellness Matrix Group, Inc.

ETFs holding Phreesia, Inc.

  • XITK — State Street SPDR FactSet Innovative Technology ETF (0.62%)
  • SFLO — VictoryShares Small Cap Free Cash Flow ETF (0.40%)
  • AFSM — First Trust Active Factor Small Cap ETF (0.34%)
  • ISMD — Inspire Small/Mid Cap ETF (0.21%)

News

Latest Market News